Abiopharma

Ensysce Biosciences Secures Second Financing From 2025 Agreement to Advance Breakthrough Pain Programs

New Form SCHEDULE 13G/A - BNY Mellon Municipal Bond Infrastructure Fund, Inc. <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001445546-26-002473 <b>Size:</b> 15 KB

Savara Inc. - Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

EVAXION A/S (EVAX) Files Form 6-K

Academy Sports + Outdoors Announces Preliminary First Quarter Fiscal 2026 Sales Update Ahead of its Analyst Day

Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

Savara Announces the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Has Accepted the MOLBREEVI* Marketing Authorisation Application (MAA) for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

Morningstar DBRS Marks 50 Years of Credit Ratings; Advances Global Methodology Program and Asia-Pacific Growth

📋 Darwish Mohamad (EVP, IHS Nigeria Chief Executive Officer) plans to sell 28K shares of IHS Holding Ltd (at $8.31 each, total $233K) Filed: Apr 07, 2026 | ID: 000140

New Form SCHEDULE 13G/A - abrdn Income Credit Strategies Fund <b>Filed:</b> 2026-04-07 <b>AccNo:</b> 0001445546-26-002471 <b>Size:</b> 15 KB

Valeo - Déclaration des droits de vote - Mars 2026

Valeo - Voting rights - March 2026

Johnson & Johnson - Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe